SCHEMBL5728818

SCHEMBL5728818

COC1CC(C)(C)Oc2ccsc21

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.35
HRH4 Q9H3N8 2/20 0.35
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9146077 0.77 MEN1 (0.38) CNR1CNR2
SCHEMBL9255825 0.74 TAAR1 (0.33)
SCHEMBL27351178 0.67 KDM4E (0.30)
SCHEMBL9749322 0.66 KDM4E (0.43) CNR1CNR2
SCHEMBL13952741 0.64 L3MBTL1 (0.35) CNR1CNR2
SCHEMBL11727643 0.60 HRH1 (0.39) HRH1HRH4
SCHEMBL9254332 0.60 L3MBTL1 (0.34)
SCHEMBL18361627 0.59 TRPV1 (0.41) CNR1CNR2
SCHEMBL9382459 0.59 ALDH1A1 (0.34)
SCHEMBL9146295 0.59 IDO1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1135394-B1 SPIROCYCLIC THIENOPYRANS AS POTASSIUM CHANNEL ACTIVATORS CAMBRIDGE BIOCLINICAL LTD (GB) 2006-03-01 EP disclosed
US-6342517-B1 THIENOPYRAN COMPOUNDS AS HYPOTENSIVE AGENTS CAMBRIDGE BIOCLINICAL LIMITED (GB) 2002-01-29 US disclosed